US FDA grants Breakthrough Device designation to CorFlow Infusion System
CorFlow Therapeutics has announced that the company has been granted Breakthrough Device designation from the US Food and Drug Administration (FDA) for its Controlled...
Cardionovum’s coronary DCB receives regulatory approval in China
Cardionovum's Restore paclitaxel-coated balloon for coronary applications has received market approval for use in China. It can be used in treating two indications: in-stent...
Corindus’ stockholders approve acquisition by Siemens Healthineers
The stockholders of Corindus Vascular Robotics have approved the adoption of the agreement and plan of merger that was drawn up in August by Siemens...
Two further studies support three-month DAPT following PCI
Further evidence for a shorter duration of dual antiplatelet therapy (DAPT) in patients implanted with a drug eluting stent has been provided with the...
